March 29, 2022 · STOCK Act disclosure
Representative William R. Keating (Democrat-MA) bought Vertex Pharmaceuticals Incorporated, a stock transaction, valued at $1,001 - $15,000. The trade took place on March 29, 2022 and was disclosed on May 5, 2022 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.